ABSTRACT
INTRODUCTION
Cardiovascular diseases (CVD) are the most common causes of mortality in patients with chronic kidney diseases (CKD) (1) . In the etiology of atherosclerotic CVD that have an increased frequency in this population, classical risk factors, such as diabetes mellitus, hypertension, dyslipidemia, obesity, etc., as well as increased inflammation, oxidative stress, anemia, and dysregulated bone and mineral metabolism play an important role (2) . The profile of vascular diseases observed in patients with end-stage renal disease (ESRD) differs from general population. In general population, intimal atherosclerotic plaque pathologies are common, whilst among the patients with CKD, in addition to this pathology, medial calcification is determined (3, 4) .
Vascular calcification is a condition that is frequently encountered in diseases such as chronic kidney failure, diabetes, hypertension, atherosclerosis, in which endothelial damage occurs and is associated with increased morbidity and mortality in even younger ages (5) . The studies performed within the last 25 years have demonstrated that inflammation and acquired immunity play a significant role in the development of atherosclerotic plaques (6) . Coronary artery calcification is an index of the severity of atherosclerotic vascular disease, and may predict future adverse cardiovascular events especially in uremic patients undergoing hemodialysis (HD) (7) . In patients with ESRD, vascular calcification was found to be associated with advanced age, male gender, non-black race, duration and adequacy of dialysis, serum calcium x phosphorus product and phosphorus level, vitamin D therapy and hyperparathyroidism (8, 9) . Moreover, the patients with ESRD are exposed to increased oxidative stress bearing (10) . In this population, the defects in nitric oxide (NO) metabolism are considered to be a part of excessive atherosclerosis (11) . Nitrotyrosine is one of the end products of NO metabolism and is accepted as an indicator of oxidative stress. In a study describing the autopsy results of the patients with ESRD, when the aorta specimens were dyed with immunologic stains, TNF-α and nitrotyrosine were found in the majority of these patients in comparison with the control group (12) .
In our study, we aimed to ascertain the relationship between nitrotyrosine, an indicator of oxidative stress, and coronary artery calcification in HD and peritoneal dialysis (PD) patients.
MATERIALS AND METHODS
The study population consisted of 80 patients with ESRD who had been undergoing dialysis for at least 6 months. Of these 80 patients participated in the study, 46 patients (male/female=28/18) were undergoing peritoneal dialysis and 34 patients (male/female=20/14) were under hemodialysis treatment. The mean age of PD and HD patients were 50,43±15 and 47,74±12,33 years, respectively. After receiving the approval of the ethics committee, the study was started; all patients first read and signed the informed consent form to participate in the study. The exclusion criterias of the study were patients receiving hemodialysis for a period shorter than six months, a history of severe trauma, surgical operations or burns within the past one month and the patients having symptomatic and decompensated liver disease.
Our study was designated as a cross-sectional study. The patients were performed whole blood count, routine biochemical analyses and coronary artery calcium score (CACS) analyses with multi-slice computerized tomography which were previously taken for coronary artery atherosclerosis screening. Venous blood samples for biochemical analyses were drawn after an overnight fast before first exchange in PD patients and before the midweek session in patients receiving HD. The blood samples that were collected within plain tubes were centrifuged at 5000g for 5 minutes so that the serum was separated. The specimens were put into the eppendorf tubes and stored at -80°C until ELISA analyses. For all patients included in the study, age, gender, body weight, body mass index, primary diseases and duration of dialysis were recorded. The systolic blood pressure (SBP) and diastolic blood pressure (DBP) of patients were measured. Patients with SBP and DBP >140 mmHg and 90 mmHg, respectively, or who were already on antihypertensive treatment were accepted to be hypertensive. HD patients were receiving dialysis with bicarbonate using semisynthetic dialysis membrane for duration of 4 hours, 3 times a week. PD patients included in the study were performing 4 exchanges a day; 41 patients were using a low-calcium dialysate, whilst 5 patients were using high-calcium dialysate.
Coronary artery calcium scoring (CACS)
The coronary artery calcium scoring was done with 64-MDCT scanner (Somatom Sensation 64, Siemens Medical Solutions, Erlangen, Germany). During the examination, the heart was scanned in cranio-caudal direction, from the carina to the apex. During the procedure, it was achieved 140 kV tube voltage, 190 mAseff effective tube current-time product, 24x1,2 mm collimation, 2.8 mm table support per rotation, and 33 ms tube rotation time. For every patient, 65% R-R reconstruction was prepared at a medium smooth convolution kernel (B35f) and a 512x512 reconstruction matrix. Then, all images were reconstructed and transferred to an external environment (Leonardo, Siemens Medical Solutions, Erlangen, Germany) for calcium scoring (Syngo Calcium Scoring CT, Siemens, Germany). The coronary calcium score was calculated considering a cut-off of 130 HU as described by Agatston et al. (13) .
Depending on the CACSs, the patients were divided into 4 groups, those with CACS 0 (group 1), the patients with low calcium scores (CACS 1-9, Group 2), those with medium calcium scores (CACS 10-399, Group 3) and the patients with high calcium scores (CACS≥400, Group 4).
Statistical analysis
The data were entered on a computer using SPSS (statistical package for social science) software version 17.0. The results were presented as mean ± standard deviation and % percentage. The analyses for the compliance with normal distribution were done. For the comparison of two groups, group analyses were done with Freidman test after determination of median and standard deviation values with descriptive tests. To compare to percentages, Fischer's exact and chi-square tests were used. Any p value<0.05 was considered to be significant. Tables 1 and 2 show demographic, clinic, and biochemical parameters of the patients with ESRD who were included in our study. There was no difference between demographic features of PD and HD patients. There was also no difference between the use of vitamin D and the use of calcium-containing phosphorus binders (Table 1) . When the clinical features and biochemical values of PD and HD patients were compared, the mean Ca and P levels and Ca x P product of HD patients were significantly higher than PD patients. Similarly, the mean albumin, ferritin, LDL cholesterol and hemoglobin values of HD patients were significantly higher than PD patients ( Table 2 ).
RESULTS
The mean age of 46 patients in the PD group was 50.43±15 years; 28 of these patients were men and 18 patients were women. The mean age of 34 HD patients (20 men and 14 women) was 47.74±12.33 years. According to the knowledge obtained from the medical records of the patients in the PD group, the causes of renal failure were polycystic kidney (n=1), amyloidosis (n=1), IgA nephropathy (n=1), chronic pyelonephritis (n=1), hypertension (n=5), diabetic nephropathy (n=4) and nephrolithiasis (n=2). For 31 PD patients, the reason of chronic renal failure was unknown. In the hemodialysis group, the causes of renal failure were amyloidosis (n=1), IgA nephropathy (n=1), nephrolithiasis (n=2), glomerulonephritis (n=2), polycystic kidney (n=3), diabetic nephropathy (n=3). The etiology of chronic renal failure was unknown in 22 patients. The mean CAC score of the patients with ESRD was found to be 241.1±339.7 cm3. When these patients were divided depending on their renal replacement treatment, the CAC scores of PD and HD patients were found to be 225.12±285.87 and 262.75±405.09 cm3, respectively (p=0.627) ( Table 2) .
The mean nitrotyrosine level of all patients was 13.37±12.3 nM. When PD and HD patients were compared with respect to nitrotyrosine levels, it was found that the hemodialysis patients had higher levels of nitrotyrosine (PD vs. HD, 9.58±3.28 nM, 18.49±17.47 nM, respectively, p<0.0001) ( Table 2 ). When PD patients were divided into 4 groups depending on their CACS, there was a significant relationship between the levels of nitrotyrosine and CACS. The nitrotyrosine level increased as CAC score became greater (r=0.343, p=0.031) ( Table 3 ). No significant relationship was found between CACS and nitrotyrosine in HD patients as a result of comparison of 4 groups formed on the basis of CACS (p=0.95).
DISCUSSION
In our study, we investigated the relationship between nitrotyrosine, an indicator of oxidative stress and vascular calcification in patients with ESRD undergoing either PD or HD treatment. The main consequences of our study can be summarized as follows: i) the nitrotyrosine levels of HD patients were significantly higher in comparison of PD patients, ii) when PD and HD patients were divided into subgroups depending on their CACS, nitrotyrosine levels increased as CACS became greater in PD patients, but this association was not found in HD patients. In patients with CKD, a significant correlation was found between increased oxidative stress, impaired NO metabolism and endothelial dysfunction. Endothelium-derived NO is an effective vasodilator and also has anti-atherogenic properties. Increased oxidative stress causes the formation of superoxide and this oxygen radical generates peroxynitrite, a product of NO metabolism, interacting with NO. The nitrotyrosine, an indicator of vascular oxidative stress, is generated as a result of the interaction of peroxynitrite with tyrosine residues (14). Massy et al. (11) demonstrated that nitrosative stress increased in chronic HD patients, but plasma nitrotyrosine levels of these patients were within normal ranges. On the other hand, Guilgen et al. (4) evaluated the external iliac and renal arteries of 27 patients with ESRD, who underwent renal transplantation as to oxidative stress and showed immunohistochemically that these patients had much more higher nitrotyrosine in comparison with the control group. In our study, it was found that serum nitrotyrosine levels of HD patients were significantly higher in comparison with PD patients. In the past, inflammation and oxidative stress that occur due to prolonged use of catheters as vascular access and the use of non-biocompatible membranes were more common in HD patients than PD patients; currently, with the widespread availability of biocompatible membranes, inflammation and oxidative stress occur less frequently in HD patients in comparison with PD patients (15) .
Hye In Kim et al. found that prevalence of vascular calcification on plain radiography was not different according to dialysis modality (16) . In our previous study (17) we found that coronary artery calcification and thoracic periaortic calcification was not differ in HD and PD patients.
In present study also we couldn't find significant relation between HD and PD patients according to vascular calcification. In an autopsy study carried out by Koleganova et al. on 31 ESRD patients, the aortas of these patients were compared to the control group and it was found immunohistochemically that aorta specimens of these patients contained very high amounts of TNF-α and nitrotyrosine (12) . In another autopsy study evaluating vascular calcification of renal and iliac arteries, it was found a positive correlation between immunohistochemically increased nitrotyrosine and vascular calcification (4). In our study, it was found that nitrotyrosine levels increased in correlation with elevated CACS in PD patients. The reason of why the same correlation wasn't demonstrated in HD patients is thought to be due to the small number of HD patients participating in the study.
The most important limiting factor in our study is the small number of patients. Moreover there isn't a control group in our study. Additionally, computed tomography techniques are not successful enough to distinguish medial from intimal calcification. We think that testing other markers in addition to nitrotyrosine as the indicators of oxidative stress could be more convenient to assess oxidative stress. In conclusion, in our study, oxidative stress was found to be increased in patients with ESRD. Particularly in PD patients, oxidative stress increased as CACS became greater. This condition indicates that there is a close relationship between vascular calcification and oxidative stress in this population.
